about
Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulationInterleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actionsHDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repressionPulsed Electromagnetic Field Regulates MicroRNA 21 Expression to Activate TGF-β Signaling in Human Bone Marrow Stromal Cells to Enhance Osteoblast Differentiation.A positive role of microRNA-15b on regulation of osteoblast differentiation.Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells.Parathyroid hormone regulates histone deacetylase (HDAC) 4 through protein kinase A-mediated phosphorylation and dephosphorylation in osteoblastic cellsCellular and molecular mechanisms of bone remodeling.Intervariability among serum intact parathyroid hormone assays: a need for standardization.HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection.EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.Sirtuin 1 is a negative regulator of parathyroid hormone stimulation of matrix metalloproteinase 13 expression in osteoblastic cells: role of sirtuin 1 in the action of PTH on osteoblasts.Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo.The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposityTranscription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activationDMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.PTH Signaling and Epigenetic Control of Bone Remodeling.Parathyroid hormone regulates histone deacetylases in osteoblasts.Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 geneParathyroid hormone signaling in bone and kidney.CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone.Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo.Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.Runx2, a target gene for activating transcription factor-3 in human breast cancer cells.Synthesis and characterization of nanoscale-hydroxyapatite-copper for antimicrobial activity towards bone tissue engineering applications.Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.Expression of microRNA-30c and its target genes in human osteoblastic cells by nano-bioglass ceramic-treatment.Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts.Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2.Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells.Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells.Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent.Constitutive expression and regulation of collagenase-3 in human breast cancer cells.Increased osteoblastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 3',5'-monophosphate response element-binding protein at serine 133.Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells.Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells.MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton.Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin.
P50
Q28569374-0DB65298-F98B-4BEB-B93D-0A24A6278EF6Q28580087-CFC8423E-6CBA-4441-B3EE-81B63CBB940CQ28582316-7FB70B75-0AB8-4C42-83D7-57319B5F71CAQ33645449-4EE95B78-9F60-4FC5-BA10-5DE64885EEC0Q33685408-EFDE2F30-1702-478A-AE96-9B3C409561D3Q33962427-7DCCDE90-DCE4-4CB1-9AE6-580AB111F928Q33985257-645C2C9C-4C05-493C-8F20-9C2E5E678FD2Q34055657-BB862FD7-371C-41AF-8D7E-840DF8DA9279Q34083341-D1DB7994-7D74-4114-8AB5-976E23E111F4Q34967056-055AEAFC-D745-487E-A2F2-DCEB3F2A8499Q35036375-715C563B-12A5-4ED8-A4DF-59173B8F36F2Q35221579-29889890-9197-4511-841D-15C12C89C229Q35229908-A8D7B8D7-4CCC-40F5-BCDD-459FF0807F45Q35504486-5DA8A89C-5830-47C4-BB47-5A0EDE323E66Q36258299-CD83483B-2D02-428F-84EF-78BB55D1F13EQ36268359-73E6F6ED-38E1-41C9-BA14-EF21586F7198Q36466986-9119F6B8-5B41-45D3-9784-033D60F6B133Q36858233-D64E5DA2-E210-4C5F-AC73-D63092051B84Q36893353-03421F6B-4FA3-432F-A8D7-E1EA698E0957Q37110385-5E89FB29-8C02-4143-89D5-F6E71501978EQ37283637-19C002EE-2361-43C1-BE87-12D8092DF3D9Q37460718-AB8A06A3-FC50-4A8B-AC21-CD50A9157B2CQ37729555-DCFFC25E-2E42-49C8-A5F2-4FBD0F314C3CQ38313913-A75032A7-A6C5-48F7-9F84-55DDD236F416Q38800361-8597DE7B-C07D-4C0A-8BBF-64817CB268D0Q38941815-0794D382-CB06-438B-B3C8-E1B228E38ACBQ39591853-840C5FCB-6B3B-427B-B65C-A9B5943FCD7EQ39828189-3E5A96AB-0EC0-4DB8-A0AE-3AF71717420BQ40060448-31197339-9BC3-41F0-9641-081A6F9C9F18Q40095819-9C1B8D75-ED14-4602-8B22-45858F724C2EQ40585969-F2A02227-25E5-4D0E-ACEE-2EEA6B62B40BQ40686388-67B65DFF-BF77-498C-BEF2-3813EE5F8421Q40713005-4C089092-F1B3-4A00-B073-636B997B6DA0Q40838608-197AADBE-D80B-4716-9D96-20D1EE33BEA6Q40868944-3AC441EA-0875-4F40-B660-C41F09C7C32BQ40968969-3872559D-8020-4977-A7FB-9C5A7A09C156Q41103225-E3D840DF-75DC-4573-AA70-3CACC2BE9CC6Q41269750-79E1ADAD-4805-4E3A-A425-253E5D255045Q41854041-08E6C02A-23F0-4277-B6D0-99E88C20E0A7Q42451131-996A0917-BB49-49A2-B183-2ACE9FC29D2F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicola C Partridge
@ast
Nicola C Partridge
@en
Nicola C Partridge
@es
Nicola C Partridge
@nl
Nicola C Partridge
@sl
type
label
Nicola C Partridge
@ast
Nicola C Partridge
@en
Nicola C Partridge
@es
Nicola C Partridge
@nl
Nicola C Partridge
@sl
prefLabel
Nicola C Partridge
@ast
Nicola C Partridge
@en
Nicola C Partridge
@es
Nicola C Partridge
@nl
Nicola C Partridge
@sl
P106
P21
P31
P496
0000-0002-5406-4814